Gender differences in the incidence of AD and vascular dementia

Objective: To study the difference in risk for dementing diseases between men and women. Background: Previous studies suggest women have a higher risk for dementia than men. However, these studies include small sample sizes, particularly in the older age groups, when the incidence of dementia is highest. Methods: Pooled analysis of four population-based prospective cohort studies was performed. The sample included persons 65 years and older, 528 incident cases of dementia, and 28,768 person-years of follow-up. Incident cases were identified in a two-stage procedure in which the total cohort was screened for cognitive impairment, and screen positives underwent detailed diagnostic assessment. Dementia and main subtypes of AD and vascular dementia were diagnosed according to internationally accepted guidelines. Sex- and age-specific incidence rates, and relative and cumulative risks for total dementia, AD, and vascular dementia were calculated using log linear analysis and Poisson regression. Results: There were significant gender differences in the incidence of AD after age 85 years. At 90 years of age, the rate was 81.7 (95% CI, 63.8 to 104.7) in women and 24.0 (95% CI, 10.3 to 55.6) in men. There were no gender differences in rates or risk for vascular dementia. The cumulative risk for 65-year-old women to develop AD at the age of 95 years was 0.22 compared with 0.09 for men. The cumulative risk for developing vascular dementia at the age of 95 years was similar for men and women (0.04). Conclusion: Compared with men, women have an increased risk for AD. There are no gender differences in risk for vascular dementia.

[1]  C. Brayne,et al.  Incidence of Clinically Diagnosed Subtypes of Dementia in an Elderly Population , 1995, British Journal of Psychiatry.

[2]  A. Stone,et al.  Predictors of survival with Alzheimer's disease: a community-based study , 1995, Psychological Medicine.

[3]  K. Andersen,et al.  Prevalence of very mild to severe dementia in Denmark , 1997, Acta neurologica Scandinavica.

[4]  A Hofman,et al.  The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. , 1991, International journal of epidemiology.

[5]  Diederick E Grobbee,et al.  Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study , 1995, BMJ.

[6]  M J Kelleher,et al.  A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule: I. Development and reliability , 1976, Psychological Medicine.

[7]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[8]  C. Brayne,et al.  Incidence of dementia in a population older than 75 years in the United Kingdom. , 1994, Archives of general psychiatry.

[9]  T. Tombaugh,et al.  The Mini‐Mental State Examination: A Comprehensive Review , 1992, Journal of the American Geriatrics Society.

[10]  A. Mooradian Antioxidant properties of steroids , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  D. Dorsa,et al.  Estrogen modulates the growth-associated protein GAP-43 (Neuromodulin) mRNA in the rat preoptic area and basal hypothalamus. , 1993, Neuroendocrinology.

[12]  E. Barrett-Connor Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. , 1997, Circulation.

[13]  F. Sohrabji,et al.  Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Léránth,et al.  Estrogen induces synaptic plasticity in adult primate neurons. , 1993, Neuroendocrinology.

[15]  E M Wijsman,et al.  Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. , 1996, American journal of human genetics.

[16]  J. Robine,et al.  The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data. , 1992, International journal of epidemiology.

[17]  Anthony F. Jorm,et al.  The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.

[18]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[19]  B. Winblad,et al.  Very Old Women at Highest Risk of Dementia and Alzheimer's Disease , 1997, Neurology.

[20]  Hiromitsu Iwamoto,et al.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population , 1995, Neurology.

[21]  J. Bauer,et al.  The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. , 1992 .

[22]  A. Hofman,et al.  Rates and risk factors for dementia and Alzheimer’s disease , 1999, Neurology.

[23]  P. Greengard,et al.  Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. , 1994, The Journal of biological chemistry.

[24]  V. Henderson,et al.  Estrogen replacement therapy and risk of Alzheimer disease. , 1996, Archives of internal medicine.

[25]  L A Beckett,et al.  Age-specific incidence of Alzheimer's disease in a community population. , 1995, JAMA.

[26]  E M Wijsman,et al.  Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.

[27]  F. Huppert,et al.  CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.

[28]  L. Sheppard,et al.  Predictors of mortality in patients diagnosed with probable Alzheimer's disease , 1996, Neurology.

[29]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[30]  A. Hofman,et al.  Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980–1990 prevalence findings , 1991, Annals of neurology.

[31]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[32]  Hyun Chul Lee,et al.  Low-Dose Growth Hormone Treatment with Diet Restriction Accelerates Body Fat Loss, Exerts Anabolic Effect and Improves Growth Hormone Secretory Dysfunction in Obese Adults , 1999, Hormone Research in Paediatrics.

[33]  G. Saade,et al.  Hormonal status affects the reactivity of the cerebral vasculature. , 1995, American journal of obstetrics and gynecology.

[34]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[35]  R B D'Agostino,et al.  Incidence of dementia and probable Alzheimer's disease in a general population , 1993, Neurology.

[36]  J. Growdon,et al.  Multiple etiologies for Alzheimer disease are revealed by segregation analysis. , 1994, American journal of human genetics.

[37]  D Commenges,et al.  Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. , 1994, International journal of epidemiology.